|
ANTI-RATIONING AMENDMENT TO
HEALTH CARE BILL
DEFEATED 12-10 IN SENATE COMMITTEE
WASHINGTON- The Senate Health,
Education, Labor and Pensions Committee today
defeated on a party-line vote an amendment
offered by Senator Michael Enzi of Wyoming, the
ranking Republican member to the pending health
care restructuring bill that would have
prevented the use of “comparative effectiveness”
research methodologies as a basis for denial of
benefits to patients against their will based on
their age, expected length of life, or of the
patient’s present or predicted disability or
quality of life. Senators Enzi, Gregg, Coburn
and Burr spoke in favor of the amendment.
In one example in the medical
literature, an attempt was made to assess
different “quality adjusted life year” scores
for each of the following: “no physical
disability, limp, walk with crutches, and need a
wheelchair.”
[i] In
another, the authors wrote, “[I]t may be judged
that one year of life with a moderate disability
is equivalent to 0.75 years of life at optimal
health.”[ii]
Senator Barbara Mikulski (D-Md)
lead the opposition to the amendment, claiming
it was unnecessary. However, while the existing
bill language says that comparative
effectiveness research such as this “shall not
be construed as mandates FOR payment, coverage,
or treatment,” nothing in the current bill
prevents it being used to DENY treatment.
“The current sources of funds
being considered to pay for health care
restructuring are so inadequate in the long term
that rationing will be compelled,” charged
Burke Balch, director of the National Right to
Life Committee’s Powell Center for Medical
Ethics. “By rejecting the Enzi amendment,
the Senate HELP Committee today cleared the way
for that rationing to be based on discrimination
against people with disabilities, older people,
and anyone considered to have a poor ‘quality of
life.’”
[i].
Duru, G, Auray, J P, Beresniak, A,
Lamure, M, Paine, A, & Nicoloyannis, N
(2002). Limitations of the methods used
for calculating
quality-adjusted-life-year values.
Pharmacoeconomics, 20, 463-73.
[ii].
A.
Atherly, S.D. Cutler, E.R. Becker. “The
Role of Cost Effectiveness Analysis in
Health Care Evaluation,” The Quarterly
Journal of Nuclear Medicine 2000 June;
44 (2): 112-120.
The National Right to
Life Committee is the nation’s largest
pro-life group with affiliates in all 50
states and over 3,000 local chapters
nationwide. National Right to Life
works through legislation and education
to protect those threatened by abortion,
infanticide, euthanasia and assisted
suicide.
# # #
|